Castilla y León confirms its "determined and prudent" commitment to the introduction of biosimilars. This was revealed by both the General Director of Health Care of the Regional Health Management (Sacyl), José Jolín, and the technical director of Pharmacy of the department, Nieves Martín Sobrino, within the framework of the Expert Meeting 'The management of biosimilars in Castilla y León' organized by Diariofarma in Valladolid, where specialists from the León and Salamanca hospitals also took part, as well as representatives of patients and industry.